Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platform

被引：0
|
作者：
Frederick M. Howard
Gong He
Joseph R. Peterson
J. R. Pfeiffer
Tyler Earnest
Alexander T. Pearson
Hiroyuki Abe
John A. Cole
Rita Nanda
机构：
[1] University of Chicago,Department of Medicine
[2] SimBioSys,Department of Radiology
[3] University of Chicago,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 196卷
关键词：
Neoadjuvant chemotherapy; MRI; Simulation; Pathologic complete response; Prognostic Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：57 / 66
页数：9
相关论文
共 50 条
  • [41] Biological correlates associated with high-risk breast cancer patients identified using a computational method
    Oh, Jung Hun
    Pareja, Fresia
    Elkin, Rena
    Xu, Kaiming
    Norton, Larry
    Deasy, Joseph O.
    NPJ BREAST CANCER, 2025, 11 (01)
  • [42] Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer
    Anita Mamtani
    Julie J. Gonzalez
    Dayna T. Neo
    Robb S. Friedman
    Abram Recht
    Michele R. Hacker
    Ranjna Sharma
    Annals of Surgical Oncology, 2018, 25 : 1495 - 1501
  • [43] Early intensive and myeloablative adjuvant chemotherapy in women with high-risk breast cancer
    Wörmann, B
    Meden, H
    Riggert, J
    Humpe, A
    Wulf, G
    Koch, B
    Köhler, M
    Kuhn, W
    Hiddemann, W
    ANTICANCER RESEARCH, 1998, 18 (3C) : 2237 - 2241
  • [44] Treatment Strategies in Octogenarians with Early-Stage High-risk Breast Cancer
    Gonzalez, J. J.
    Neo, D.
    Friedman, R. S.
    Recht, A.
    Hacker, M. R.
    Sharma, R.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S47 - S47
  • [45] Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer
    Mamtani, Anita
    Gonzalez, Julie J.
    Neo, Dayna T.
    Friedman, Robb S.
    Recht, Abram
    Hacker, Michele R.
    Sharma, Ranjna
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1495 - 1501
  • [46] Role of dose-dense chemotherapy in high-risk early breast cancer
    Blondeaux, Eva
    Poggio, Francesca
    Del Mastro, Lucia
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 480 - 485
  • [47] Optimal Chemotherapy for High-Risk Early-Stage Breast Cancer Reply
    Levine, Mark N.
    Chapman, Judith-Anne W.
    O'Brien, Patti Susan
    Shepherd, Lois E.
    Burnell, Margot J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : E264 - E264
  • [48] COGNITION/-GUIDE - Implementation of Precision Oncology in Early High-Risk Breast Cancer
    Thewes, Verena
    Strassl, Luise
    Zapatka, Marc
    Hlevnjak, Mario
    Pixberg, Constantin
    Maurer, Christian
    Smetanay, Katharina
    Fremd, Carlo
    Michel, Laura
    Heublein, Sabine
    Wagner, Celina V.
    Suppelna, Jan-Philip
    Buschhorn, Lars
    Stenzinger, Albrecht
    Haidinger, Renate
    Schumacher-Wulf, Eva
    Loibl, Sibylle
    Wimberger, Pauline
    Blohmer, Jens-Uwe
    Fasching, Peter A.
    Janni, Wolfgang
    Schlenk, Richard F.
    Lichter, Peter
    Schneeweiss, Andreas
    CANCER RESEARCH, 2024, 84 (09)
  • [49] Neoadjuvant endocrine therapy with palbociclib in patients with high-risk breast cancer
    Lonning, P. E.
    Clausen, C.
    Blix, E. S.
    Lundgren, S.
    Vagstad, G.
    Espelid, H.
    Gilje, B.
    Janssen, E. A.
    Geisler, J.
    Aas, T.
    Aase, H.
    Knappskog, S.
    Eikesdal, H. P.
    ANNALS OF ONCOLOGY, 2019, 30 : 59 - +
  • [50] ETC-Regime: Help for High-risk breast cancer patients
    Moebus, Volker
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (05) : 367 - 369
12345